Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07130136

Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients

Post-Market Clinical Follow-Up of the Osia System and Evaluation of Benefits of Transitioning From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients With Mixed or Conductive Hearing Loss

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Cochlear · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this interventional study is to confirm the safety and performance of the latest generation Osia System and to examine its benefits compared to the Baha Connect System in adults with mixed or conductive hearing loss who have a pre-existing Baha implant and Abutment (BIA300) and are transitioning to the Osia System. The main questions this study aims to answer are: * Is the safety and performance of the Osia System confirmed by study findings? * What are the benefits of the Osia System compared to the Baha Connect System? Participants will: * Undergo speech performance testing in both quiet and noisy environments * Provide ratings for various questionnaires

Conditions

Interventions

TypeNameDescription
DEVICECochlear™ Osia® SystemThe Osia System consists of the OSI300 Implant, Osia 2 Sound Processor, Osia 2 Sound Processor Magnets, Osia 2 Sound Processor Magnet Tool, Osia Fitting Software 2 (OFS 2), and Osia Smart App.
DEVICECochlear™ Baha® SystemThe Baha Connect System consists of the BIA300 (BI300 Implant and BA300 Abutment), Baha 7 Sound Processor, and Baha Fitting Software 7 (BFS 7).

Timeline

Start date
2026-05-01
Primary completion
2028-11-01
Completion
2028-12-01
First posted
2025-08-19
Last updated
2026-02-11

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07130136. Inclusion in this directory is not an endorsement.